Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,801 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Macrophage hypoxia signaling regulates cardiac fibrosis via Oncostatin M.
Abe H, Takeda N, Isagawa T, Semba H, Nishimura S, Morioka MS, Nakagama Y, Sato T, Soma K, Koyama K, Wake M, Katoh M, Asagiri M, Neugent ML, Kim JW, Stockmann C, Yonezawa T, Inuzuka R, Hirota Y, Maemura K, Yamashita T, Otsu K, Manabe I, Nagai R, Komuro I. Abe H, et al. Among authors: yamashita t. Nat Commun. 2019 Jun 27;10(1):2824. doi: 10.1038/s41467-019-10859-w. Nat Commun. 2019. PMID: 31249305 Free PMC article.
Echocardiographic predictors of frequency of paroxysmal atrial fibrillation (AF) and its progression to persistent AF in hypertensive patients with paroxysmal AF: results from the Japanese Rhythm Management Trial II for Atrial Fibrillation (J-RHYTHM II Study).
Suzuki T, Yamazaki T, Ogawa S, Nagai R, Yamashita T; J-RHYTHM II Investigators. Suzuki T, et al. Among authors: yamashita t. Heart Rhythm. 2011 Dec;8(12):1831-6. doi: 10.1016/j.hrthm.2011.07.035. Epub 2011 Aug 2. Heart Rhythm. 2011. PMID: 21816128 Clinical Trial.
ABO Blood Type and Response of Activated Partial Thromboplastin Time to Dabigatran in Nonvalvular Atrial Fibrillation Patients.
Suzuki S, Otsuka T, Sagara K, Semba H, Kano H, Matsuno S, Takai H, Kato Y, Uejima T, Oikawa Y, Nagashima K, Kirigaya H, Kunihara T, Yajima J, Sawada H, Aizawa T, Yamashita T. Suzuki S, et al. Among authors: yamashita t. Circ J. 2015;79(10):2274-7. doi: 10.1253/circj.CJ-15-0386. Epub 2015 Aug 27. Circ J. 2015. PMID: 26310875 Free article. Clinical Trial.
Nine-Year Trend of Anticoagulation Use, Thromboembolic Events, and Major Bleeding in Patients With Non-Valvular Atrial Fibrillation　- Shinken Database Analysis.
Suzuki S, Otsuka T, Sagara K, Semba H, Kano H, Matsuno S, Takai H, Kato Y, Uejima T, Oikawa Y, Nagashima K, Kirigaya H, Kunihara T, Yajima J, Sawada H, Aizawa T, Yamashita T. Suzuki S, et al. Among authors: yamashita t. Circ J. 2016;80(3):639-49. doi: 10.1253/circj.CJ-15-1237. Epub 2016 Jan 21. Circ J. 2016. PMID: 26794283 Free article.
Impact of BNP level and peak VO2 on future heart failure events: comparison between sinus rhythm and atrial fibrillation.
Kato Y, Suzuki S, Uejima T, Semba H, Kano H, Matsuno S, Takai H, Otsuka T, Oikawa Y, Nagashima K, Kirigaya H, Sagara K, Kunihara T, Yajima J, Sawada H, Aizawa T, Yamashita T. Kato Y, et al. Among authors: yamashita t. Heart Vessels. 2017 Apr;32(4):428-435. doi: 10.1007/s00380-016-0887-x. Epub 2016 Aug 22. Heart Vessels. 2017. PMID: 27550341
6,801 results